ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Montana » Psychiatry

Top Psychiatry Prescribers in Montana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDWARD ERBE M.D.

Psychiatry

6,326

$779K

228
30 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 26%

$123
Average prescription price

Avg: $143

TERRY LANES M.D.

Psychiatry

5,600

$749K

247
32 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$134
Average prescription price

Avg: $143

TROY STILES D.O.

Psychiatry

5,427

$891K

297
56 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$164
Average prescription price

Avg: $143

PATRICIA CALKIN MD

Psychiatry

3,656

$488K

152
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$133
Average prescription price

Avg: $143

THOMAS VAN DYK MD

Psychiatry

3,309

$448K

186
61 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$136
Average prescription price

Avg: $143

JAMES WHITWORTH MD

Psychiatry

3,141

$418K

195
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$133
Average prescription price

Avg: $143

ELIZABETH WALTER MD

Psychiatry

3,125

$545K

145
47 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 26%

$174
Average prescription price

Avg: $143

PHILLIP HOLMAN MD

Psychiatry

3,014

$299K

153
28 are 65+

33%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$99
Average prescription price

Avg: $143

TORGEIR FINSAAS MD

Psychiatry

2,915

$459K

136
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$157
Average prescription price

Avg: $143

MARY EVANS MD

Psychiatry

2,417

$462K

92
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$191
Average prescription price

Avg: $143

ROBERT CALDWELL M.D.

Psychiatry

2,283

$423K

95
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 26%

$185
Average prescription price

Avg: $143

MARK NICHOLSON MD

Psychiatry

2,234

$351K

115
12 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$157
Average prescription price

Avg: $143

MARTHA RHOADES MD

Psychiatry

2,006

$211K

108
43 are 65+

24%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$105
Average prescription price

Avg: $143

EVA LAROCQUE MD

Psychiatry

1,992

$508K

89
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 26%

$255
Average prescription price

Avg: $143

ANGELA CASMIER M.D.

Psychiatry

1,900

$390K

85
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 26%

$206
Average prescription price

Avg: $143

CHARLES ELLIS M.D.

Psychiatry

1,856

$369K

147
16 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 26%

$199
Average prescription price

Avg: $143

NOEL DRURY MD

Psychiatry

1,834

$212K

93
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$115
Average prescription price

Avg: $143

LAURA SALYERS MD

Psychiatry

1,745

$196K

141
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$112
Average prescription price

Avg: $143

MARK MOZER M.D.

Psychiatry

1,505

$169K

115
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$113
Average prescription price

Avg: $143

BENNETT BRAUN M.D.

Psychiatry

1,348

$193K

36
12 are 65+

33%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 26%

$143
Average prescription price

Avg: $143

DAVID YELVINGTON MD

Psychiatry

1,330

$150K

69
31 are 65+

22%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 26%

$113
Average prescription price

Avg: $143

AMY SCHUETT M.D.

Psychiatry

1,215

$149K

154
44 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 26%

$123
Average prescription price

Avg: $143

CHRISTINE DALY

Psychiatry

1,204

$184K

81
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$153
Average prescription price

Avg: $143

BRUCE SWARNY M.D.

Psychiatry

1,202

$103K

71
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 26%

$85
Average prescription price

Avg: $143

LARRY AMSTUTZ MD

Psychiatry

1,150

$186K

61
12 are 65+

26%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 26%

$162
Average prescription price

Avg: $143

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank